Login to Your Account

Microscience Being Bought After Failed Attempt At IPO

By Nuala Moran

Wednesday, June 29, 2005
LONDON - Microscience Ltd. is being acquired by U.S. company Emergent BioSolutions Inc. in an all-paper deal that values the vaccine specialist at £40 million (US$73.1 million), roughly £5 million less than the four venture capital investors have put in to date. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription